MPOX
Category: 2026
Robust Protection Against Monkeypox Virus Mediated by a Novel Cell‑Line–Derived MVA Vaccine (TG-MVACL)
N. Silvestre, et al. World Congress on Infectious Diseases WCID 2026 Abstract available on WCID website – Download the abstract – Download the oral presentation
Transgene’s Combined General Meeting of May 22, 2026
AG 2026
Availability of Preparatory Documents for the Combined General Meeting of May 22, 2026
AG 2026
Transgene Provides Business and Financial Update for Q1 2026
Q1 2026
Synthetic Genome Shuffling of Poxviruses via Yeast TAR Cloning for Next-Generation Oncolytic Platforms
A. Agaoua et al. International Oncolytic Virus Conference 2026 – Download the Abstract – Download the Poster
Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head and Neck Cancer
TG4050
Transgene to Participate in Upcoming Investor Meetings
Investor meetings
Transgene Further Strengthens Scientific Advisory Board with Appointments of Renowned Cancer Immunotherapy Experts Antoine Italiano and Ignacio Melero
SAB Jan26